Sensex drops 700 pts, Nifty slips below 22,500 amid global and domestic pressures
Sandip Raj Gupta
10/Mar/2025

- Sensex lost 709 pts from its intraday high to 74,031.93, and Nifty slipped below 22,500, as profit-booking and weak global cues weighed on investor sentiment.
- US stock futures tumbled sharply, with Dow futures falling over 400 pts, while trade war fears and tariff uncertainties added pressure on domestic equity markets.
- Key corporate moves included Sun Pharma’s $355m acquisition, Tata Power’s ₹49,000cr MoU, and major selloffs by companies like IndusInd Bank and Alembic Pharmaceuticals.
The Indian equity markets experienced a turbulent session on Monday, marked by sharp declines in benchmark indices and a flurry of corporate news that underscored both global uncertainties and domestic challenges. In a day that began with early gains, the BSE Sensex and Nifty 50 ultimately erased those advances as profit-booking set in and global cues turned negative. This comprehensive report details the market movements, explains the key factors influencing investor sentiment, and reviews the major corporate updates that contributed to the day’s volatility.
Market Overview and Global Cues
Early in the session, there was cautious optimism among investors as domestic indices began the day with modest gains. However, the situation quickly reversed as international markets signalled deep uncertainty. A significant factor in this reversal was the steep decline in US stock futures. Reports indicated that Wall Street futures were trading with steep cuts – with Dow Jones futures falling over 400 points, S&P 500 futures dropping by more than 60 points, and Nasdaq futures losing over 250 points. These declines were partly attributed to remarks by the US President, who described the economy as being in a “period of transition,” which heightened market anxiety.
Global factors did not end there. Trade war concerns and tariff uncertainties added to the bearish sentiment. With the US Commerce Secretary announcing a 25 percent tariff on steel and aluminium imports effective from Wednesday, investors braced for the possibility of reciprocal measures. Market experts warned that such tariffs might adversely impact key export-driven sectors in India, including IT and pharmaceuticals. Furthermore, weak cues from the Asian markets contributed to the decline. Notably, the Hang Seng index in Hong Kong fell by 1.8 percent and the Shanghai Composite index slipped, reflecting broader regional economic concerns. Reports also highlighted that China’s consumer prices had declined for the first time in 13 months, signaling a potential slowdown in demand.
In response to these external pressures, investors began to offload stocks, resulting in significant losses on domestic indices. The BSE Sensex dropped by 709.32 points from its intraday high, touching a low of 74,031.93. Simultaneously, the Nifty 50 slipped below the key 22,500-mark to register a low of 22,429.05. This drop marked a significant reversal from the earlier part of the day, snapping a series of gains and reinforcing the idea that profit-booking and external pressures had overwhelmed the market’s earlier momentum.
Domestic Market Dynamics and Profit-Booking
A major contributor to the downturn was the widespread profit-booking observed during the latter part of the session. As investors sought to secure gains after the previous rally, heavy selling ensued. Capital market-focused stocks, in particular, were among the worst affected. For instance, 360 One WAM, a key stock on the smallcap index, led the losses by falling nearly 7 percent to trade at ₹906 per share after an even steeper early decline that saw it drop over 8 percent. This steep fall was the stock’s worst in three years, and its performance was indicative of the broader selloff in the smallcap segment.
The Nifty Smallcap index recorded a 2 percent decline, bringing its level to around 15,250. This downturn snapped a 4-day gaining streak that had provided a brief respite from the persistent downward pressure in previous sessions. Similarly, the Nifty Midcap index fell by 2 percent from its day’s high, settling at approximately 48,448. The fluctuations in these indices underscored the fragility of market sentiment, where even a minor trigger in global cues or domestic policy could provoke widespread selling.
While many stocks in these indices fell sharply, a few managed to buck the trend. Notably, Aavas Financiers emerged as a top gainer in the smallcap segment, rising over 6 percent to trade at ₹1,807 per share. This divergence highlights the uneven nature of the market, where individual stocks with strong fundamentals or positive corporate news can still attract buying interest even as the broader market remains under pressure.
Corporate Updates Impacting Market Sentiment
In addition to global and domestic macroeconomic factors, a series of corporate updates added further layers of complexity to the trading session. These updates ranged from regulatory actions and management changes to strategic acquisitions and significant project wins. Each corporate development had its own impact on investor sentiment, contributing to the overall volatility.
One of the prominent pieces of corporate news was the update from Alembic Pharmaceuticals. The company’s shares fell following a notice from the US FDA, which issued a Form 483 observation after an inspection at its bioequivalence facility in Vadodara. Such regulatory observations tend to raise concerns among investors about potential future compliance issues, prompting a reassessment of the stock’s risk profile.
In the banking sector, IndusInd Bank witnessed a dramatic selloff as its shares plunged to a 52-week low of ₹881.1. This decline was triggered by the Reserve Bank of India’s (RBI) decision to reappoint Sumant Kathpalia as the bank’s Managing Director and CEO for a term of just one year. The short tenure approval raised questions about management stability and future strategic direction, leading to a sharp drop in investor confidence.
Another significant corporate development came from Nazara Technologies, which sold its 94.9 percent stake in OpenPlay Technologies to Moonshine Technology—the parent company of PokerBaazi—for ₹104.3 crore. This sale signified a strategic exit from a subsidiary, as Nazara refocused on its core businesses in the gaming and digital entertainment sectors.
Tata Power added a positive note to the day’s corporate news by announcing the signing of a memorandum of understanding (MoU) with the Andhra Pradesh Government. Under this agreement, Tata Power will set up 7,000 MW of renewable power projects, including wind, solar, and hybrid systems, with a total capital expenditure of ₹49,000 crore. This ambitious renewable energy project underscores Tata Power’s commitment to sustainable development and positions the company to benefit from India’s growing renewable energy agenda.
In the pharmaceutical sector, Sun Pharmaceutical Industries made headlines with its announcement to acquire US-based Checkpoint Therapeutics for $355 million (approximately ₹3,095 crore). This strategic acquisition will bolster Sun Pharma’s oncology portfolio by adding UNLOXCYT™ (cosibelimab-ipdl)—the first FDA-approved anti-PD-L1 treatment for metastatic cutaneous squamous cell carcinoma (cSCC). The move is expected to enhance the company’s global footprint in targeted oncology therapies.
Meanwhile, Shyam Metalics and Energy reported mixed results. The company’s stainless steel sales surged by an impressive 110% year-on-year (YoY) to 8,552 million tonnes (MT) in February, and its aluminium foil sales increased by 23% YoY to 1,686 MT. However, these gains were offset by a 5% YoY decline in carbon steel sales, reflecting the challenges faced by different segments within the company’s portfolio.
Another regulatory update came from Shilpa Medicare, which received a Form 483 observation from the US FDA after an inspection at its facility, Shilpa Pharma Lifesciences' Unit-1 in Raichur. Similar to the situation faced by Alembic Pharmaceuticals, this development raises concerns about compliance and could potentially impact investor sentiment.
Analyst Opinions and Sectoral Insights
In the midst of this volatility, several research analysts and brokerage firms offered their perspectives on the market and specific sectors. Jefferies maintained a constructive stance on Indian metal stocks, noting that these stocks had outperformed the Nifty 50 by 15-20% year-to-date in 2025. Their positive outlook was driven by expectations of China’s recovery and the potential for safeguard duties on steel in India, which could benefit domestic producers. They issued a ‘Buy’ call on prominent names like Tata Steel and Hindalco Industries, while advising a ‘Hold’ rating on JSW Steel.
Adding to this, Geojit BNP Paribas upgraded CG Power and Industrial Solutions from ‘Accumulate’ to a ‘Buy’ call, setting a target price of ₹696 per share. This upgrade was based on the company’s robust export capabilities and the potential for its revenue to grow at a compound annual growth rate (CAGR) of 26.4% over FY25-27. In another sector, Nuvama retained its ‘Buy’ rating on Pidilite Industries with a target price of ₹3,660, emphasizing the company’s strategic expansion into electronics and EV adhesives along with its focus on premiumisation and innovation.
Conversely, not all news was positive. The Indian Renewable Energy Development Agency faced a setback when the RBI rejected its request for equity investment to develop a 900 MW Upper Karnali Hydro Electric Power project in Nepal. Such regulatory rejections add to the uncertainty in the renewable energy sector.
In the chemicals and process industries, Neogen Chemicals fell sharply after it reduced its revenue guidance for FY25-26 to a range of ₹765-800 crore. This revision came in the wake of a significant fire at its Multi-Purpose Plant (MPP3) in Dahej, which caused extensive damage to infrastructure, machinery, and equipment. The company anticipates that the plant will be back in operation within 9-12 months, but the incident has clearly weighed on market sentiment.
Turning to the auto and consumer sectors, Mahindra & Mahindra reported strong performance in February, with wholesales increasing by 14.8% YoY to 83,702 units. Passenger vehicle sales rose by 18.9% YoY, and export volumes nearly doubled during the month. These figures indicate robust demand in both domestic and international markets and underscore Mahindra’s resilience amid a generally volatile market environment.
Additional corporate updates include a significant trade in Bharti Airtel, where approximately 9.4 lakh shares—worth ₹153.2 crore—changed hands in a large block trade. This trade activity points to heightened investor interest in the telecom sector, even as broader market sentiments remain cautious.
Infrastructure and Contract Wins
The infrastructure segment also saw notable developments. IRB Infrastructure Developers reported an 18% YoY increase in its total toll collection for February, reaching ₹529 crore, with daily toll collections rising by 18.8% YoY to ₹19 crore. Such improvements reflect the underlying strength of the toll road segment despite the overall market volatility.
In the aviation space, GMR Airports increased its stake in Delhi International Airport (DIAL) from 64% to 74% after acquiring an additional 10% stake from Germany’s Fraport AG for approximately $126 million (₹1,099 crore). This strategic move is expected to enhance GMR’s control over one of India’s key aviation assets and improve its operational efficiency.
In another positive note for the defense and communications sector, HFCL’s subsidiary, HTL, secured a ₹44.4 crore contract from the Indian Army. The contract involves the supply of tactical optical fibre cable assemblies that are designed to withstand the rigours of military use, including the stress imposed by heavy armored vehicles. This win underscores HFCL’s growing footprint in high-end, government-backed projects.
Emerging Opportunities and Analyst Initiatives
From an equity research perspective, ICICI Securities initiated coverage on Inventurus Knowledge Solutions (IKS) with a ‘Hold’ call and a target price of ₹1,820 per share. The brokerage highlighted the potential for revenue growth driven by synergistic large acquisitions and tailwinds from the US healthcare sector, forecasting a revenue CAGR of 21.2% over FY25-27 for IKS.
In the steel industry, JSW Steel recorded a notable performance with its consolidated steel production rising 12% YoY to 24.1 lakh tonnes in February. The company’s capacity utilisation in its Indian operations stood at an impressive 93.5%, reflecting robust demand and efficient operational execution. This growth trend is expected to support JSW’s future earnings and reinforce its market position despite broader economic uncertainties.
Sectoral Performance and Future Outlook
The diverse range of corporate news reveals the complex interplay of factors affecting different sectors within the Indian economy. While global cues such as falling US stock futures and trade war uncertainties continue to exert downward pressure, several domestic developments offer contrasting signals of growth and resilience.
For instance, the renewable energy and infrastructure sectors are buoyed by large-scale projects such as Tata Power’s ₹49,000 crore MoU and GMR Airports’ strategic stake increase in DIAL. Similarly, Mahindra & Mahindra’s strong sales performance and JSW Steel’s production growth indicate robust fundamentals in the auto and steel sectors, respectively.
In contrast, certain segments face headwinds. Regulatory actions against Alembic Pharmaceuticals and Shilpa Medicare have raised compliance concerns, while the setback at Neogen Chemicals’ Dahej plant underscores the risks associated with industrial mishaps. Moreover, the financial sector is witnessing mixed signals, with IndusInd Bank hitting a 52-week low and corporate moves like Nazara Technologies’ stake sale reflecting strategic repositioning.
On the flip side, the credit rating agency Fitch Ratings maintained a negative outlook on Adani Energy Solutions, warning that ongoing investigations in the US could expose governance weaknesses and impact the company’s future access to capital markets. Despite securing substantial funding of ₹5,100 crore through both onshore and offshore facilities, the uncertainty surrounding the investigation may weigh on investor sentiment in the near to medium term.
Looking Ahead: Challenges and Opportunities
The unfolding market scenario presents both challenges and opportunities for investors. On one hand, the steep drops in benchmark indices and select stocks signal underlying vulnerabilities in a market still grappling with global headwinds, tariff concerns, and intermittent profit-booking. On the other hand, strategic corporate moves—such as Sun Pharma’s acquisition of Checkpoint Therapeutics and Tata Power’s massive renewable energy project—demonstrate that well-capitalized companies are continuing to invest in growth and innovation despite the prevailing uncertainty.
For investors, the key lies in balancing risk with opportunity. Large-cap stocks, with their relatively stable fundamentals, might offer a safer haven during periods of volatility. Meanwhile, mid-cap and small-cap stocks, although more volatile, could present attractive entry points if selected based on strong earnings growth and robust fundamentals. The current environment calls for a diversified portfolio and a careful reassessment of exposure to sectors that are most sensitive to global economic shifts and domestic regulatory developments.
The Upcoming IPOs in this week and coming weeks are Super Iron Foundry, Paradeep Parivahan, Divine Hira Jewellers.
The Current active IPO is PDP Shipping & Projects.
Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.
Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst.